ArticleAmerican journal of translational research2025
An optimizing lentiviral titer determination assay based on Raji cells.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesAccurate lentiviral titer determination is crucial for optimizing transduction efficiency in gene therapy. Traditional titration methods based on the human embryonic kidney 293T (HEK293T) cell line often encounter issues with fidelity and reproducibility. This study assessed the potential of suspension cell lines, such as Raji cells, as a more reliable platform for lentiviral titration.
methodsTransduction efficiencies were compared between HEK293T cells and various suspension cell lines, including Raji, across a range of viral doses and infection conditions, both with and without infection enhancers. Lentiviral titers were quantified using quantitative polymerase chain reaction (qPCR) with primers targeting human reference genes Albumin (ALB), Poly(RC) Binding Protein 2 (PCBP2), and lentiviral sequences including Woodchuck Hepatitis Virus (WHP) Posttranscriptional Regulatory Element (WPRE) and Group-specific antigen (
resultsRaji cells demonstrated significantly higher transduction efficiency than HEK293T cells, particularly at lower viral inputs, and maintained robust infection rates at high cell densities. qPCR-based titration revealed that functional titers in Raji cells were substantially higher than those in HEK293T cells. Moreover, infection of primary T cells using Raji-derived titers showed greater sensitivity, achieving saturation at lower viral loads compared to HEK293T-derived titers.
conclusionsRaji cells offer a more reliable and efficient platform for lentiviral titration compared to the conventional HEK293T-based method. This suspension cell-based approach holds potential for enhancing the scalability and consistency of lentiviral vector production in gene therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.